These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 13617714)

  • 1. [Properdin in the course of chronic inflammatory rheumatism; comparative study by hemolysis inhibition & neutralization of bacteriophage T2r+].
    EYQUEM A; FRANCQ JC; GUYOT-JEANNIN N; JACQUELINE F
    Ann Inst Pasteur (Paris); 1958 Dec; 95(6):748-53. PubMed ID: 13617714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incidence of adenovirus antibodies in patients with various clinical forms of chronic rheumatism].
    Athanasiu P; Broniţki A; Moisa I
    Stud Cercet Inframicrobiol; 1969; 20(3):179-83. PubMed ID: 4310663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incidence of Au-(SH)-Ag in chronic inflammatory joint diseases].
    Lehamann H; Schlaak M; Josenhans G
    Verh Dtsch Ges Rheumatol; 1974; 3(0):52-3. PubMed ID: 4209463
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: HL-A antigens in rheumatoid arthritis and ankylosing spondylitis in Sardinia].
    Marcolongo R; Contu L
    Nouv Presse Med; 1974 Sep; 3(32):2023. PubMed ID: 4431706
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of immunochemical and cytopathological parameters in rheumatoid arthritis and seronegative spondarthritis syndrome.
    Dev V; Malaviya AN; Misra R; Verma K; Banerjee S; Mehra NK; Kumar A
    J Assoc Physicians India; 1986 Apr; 34(4):253-5. PubMed ID: 3759819
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic problems in inflammatory-rheumatic diseases].
    Pohl W; Tremel R; Piening WD; Schierz G
    Med Welt; 1971 Nov; 46():1828-31. PubMed ID: 5131886
    [No Abstract]   [Full Text] [Related]  

  • 7. Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: a literature review.
    Coiffier G; Bouvard B; Chopin F; Biver E; Funck-Brentano T; Garnero P; Guggenbuhl P
    Joint Bone Spine; 2013 May; 80(3):250-7. PubMed ID: 23142254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [To the problem of antibody formation capacity in chronic p9lyarthritis].
    Meyer GJ; Müller W
    Z Rheumaforsch; 1969; 28(1):35-43. PubMed ID: 5306828
    [No Abstract]   [Full Text] [Related]  

  • 9. [Practical importance of the determination of complement and its fractions in rheumatology].
    Duquesnoy B
    LARC Med; 1981 Nov; 1(2):57-8. PubMed ID: 7052242
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sorbitol dehydrogenase (SDH) activity of the blood in chronic inflammatory rheumatism].
    Cervini C; Leofreddi L
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1667-9. PubMed ID: 5877898
    [No Abstract]   [Full Text] [Related]  

  • 11. Low frequency of chronic biological false positive reactors to serological tests for syphilis in rheumatoid arthritis and ankylosing spondylitis.
    Salo OP; Sievers K; Ahvonen P; Aho K
    Ann Rheum Dis; 1968 May; 27(3):261-3. PubMed ID: 5655318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on the evolution and prognosis of subacute rheumatism (inflammatory oligoarthritis) in the adult].
    CAMUS JP; HEBRARD C
    Presse Med (1893); 1963 Jul 3-Aug 27; 71():1711-2. PubMed ID: 14018206
    [No Abstract]   [Full Text] [Related]  

  • 13. [REHABILITATION OF PATIENTS WITH INFLAMMATORY RHEUMATISM].
    VITAUS M
    Lijec Vjesn; 1963 Apr; 85():379-88. PubMed ID: 14062740
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the treatment of arthritis and chronic rheumatism.
    SAVAGE O
    Practitioner; 1962 Oct; 189():478-84. PubMed ID: 13986871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial therapy of inflammatory rheumatism in the reeducation House].
    CODREANO ; BLANQUIER
    Rhumatologie; 1958; 10(6):255-64. PubMed ID: 13646452
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
    Herman S; Krönke G; Schett G
    Trends Mol Med; 2008 Jun; 14(6):245-53. PubMed ID: 18468489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages.
    Antoniv TT; Ivashkiv LB
    Arthritis Rheum; 2006 Sep; 54(9):2711-21. PubMed ID: 16947381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement, complement components, properdin and agglutination promoting factors in rheumatoid arthritis.
    LAURELL AB; GRUBB R
    Acta Pathol Microbiol Scand; 1958; 43(3):310-20. PubMed ID: 13594447
    [No Abstract]   [Full Text] [Related]  

  • 19. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
    [No Abstract]   [Full Text] [Related]  

  • 20. [The inhibitory activity of serum against T2r + bacteriophage in relation to properdin].
    FRANCQ JC; EYQUEM A; GUYOTJEANNIN N
    Ann Inst Pasteur (Paris); 1959 Feb; 96(2):178-83. PubMed ID: 13627583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.